🟢 Krystal Biotech is trading 4.3% up in after-hours trading

Krystal Biotech is trading 4.3% up at $360.23 after its September 10, 2026 Cantor Global Healthcare Conference presentation.

• Management discussed continued VYJUVEK expansion in Europe and Japan, alongside slower U.S. growth.
• Upcoming pipeline milestones span dermatology, ophthalmology, and oncology.
• Available coverage does not explicitly attribute the after-hours move to the conference; broader markets declined on September 10.